CD79A and COVID-19: Levels of IgA autoantibodies may be elevated as a physiologic response to the COVID-19 infection and may not be secondary to an underlying autoimmune inflammatory response, probably explaining elevated levels of autoantibodies regardless of the clinical severity of COVID-19.